Neurocytopathic effects of beta-amyloid-stimulated monocytes: a potential mechanism for central nervous system damage in Alzheimer disease.
Growing evidence indicates that cells of the mononuclear phagocyte lineage, which includes peripheral blood monocytes (PBM) and tissue macrophages, participate in a variety of neurodestructive events and may play a pivotal role in neurodegenerative conditions such as Alzheimer disease. The present study sought to determine whether exposure of PBM to beta-amyloid peptide (A beta), the major protein of the amyloid fibrils that accumulate in the brain in Alzheimer disease, could induce cytopathic activity in these cells upon their subsequent incubation with neural tissue. PBM were incubated with A beta for 3 days, centrifuged and washed to remove traces of cell-free A beta, and then applied to organotypic cultures of rat brain for varying periods of time. By using a cell-viability assay to quantitate neurocytopathic effect, an increase in the ratio of dead to live cells was detected in cultures containing A beta-stimulated PBM versus control PBM (stimulated with either bovine serum albumin or reverse A beta peptide) as early as 3 days after coculture. The ratio of dead to live cells increased further by 10 days of coculture. By 30 days of coculture, the dead to live cell ratio remained elevated, and the intensity of neurocytopathic effect was such that large areas of brain mass dissociated from the cultures. These results indicate that stimulation of PBM with A beta significantly heightens their neurocytopathic activity and highlight the possibility that inflammatory reactions in the brain play a role in the neurodegeneration that accompanies Alzheimer disease.
London
J A
JA
Department of Physiology, University of Connecticut Health Center, Farmington 06030, USA.
Biegel
D
D
Pachter
J S
JS
D000544:Alzheimer Disease / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D002417:Cattle; D002449:Cell Aggregation / Q000187:drug effects; D016923:Cell Death; D002470:Cell Survival; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000473:pathology*; D018920:Coculture Techniques; D006801:Humans; D008264:Macrophages / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D018613:Microscopy, Confocal; D009000:Monocytes / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D009474:Neurons / Q000473:pathology; D009498:Neurotoxins; D009924:Organ Culture Techniques; D051381:Rats; D012710:Serum Albumin, Bovine / Q000494:pharmacology
D016229:Amyloid beta-Peptides; D009498:Neurotoxins; D012710:Serum Albumin, Bovine